$FBIO Cashflow Statement | Understand Stock

$FBIO

$1.93 +$0.06 (3.21%) Close

$FBIO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows from Operating Activities:
Net income (loss)
Reconciliation of net loss to net cash used in operating activities:
Depreciation expense
Loss on disposal of property and equipment
Bad debt (recovery) expense
Amortization of debt discount
Oaktree Note
Total amortization of debt discount
Accretion of partner company convertible preferred shares
Non-cash interest
Amortization of product revenue license fee
Gain on termination of partner company lease
Loss on extinguishment of debt
Amortization of acquired intangible assets
Settlement of partner company payables
Reduction in the carrying amount of operating lease right-of-use assets
Stock-based compensation expense
Issuance of common stock for service
Issuance of partner company's common shares for research and development expenses
Common shares issued/issuable for dividend on partner company's convertible preferred shares
Common shares issued for 2017 Subordinated Note Financing interest expense
Change in fair value of investment in Caelum
Change in fair value of investment
Common shares issued for dividend on partner company's convertible preferred shares
Change in fair value of partner companies' warrant liabilities
Research and development - licenses acquired, expense
Loss from deconsolidation/dissolution of subsidiaries
Gain from deconsolidation of subsidiary
Asset impairment loss

Increase (decrease) in cash and cash equivalents resulting from changes in operating assets and liabilities:
Accounts receivable
Inventory
Other receivables - related party
Prepaid expenses and other current assets
Other assets
Accounts payable and accrued expenses
Interest payable
Interest payable - related party
Deferred revenue
Income taxes payable
Lease liabilities
Other liabilities

Net cash used in operating activities
Cash Flows from Investing Activities:
Acquired intangible assets
Purchase of property and equipment
Proceeds from the sale of partner company's fixed assets
Proceeds from sale of property and equipment
Other
Acquisition of Vyne products
Proceeds from sale of Caelum
Purchase of research and development licenses
Net cash increase upon deconsolidation of subsidiary
Net cash provided by (used in) investing activities

Cash Flows from Financing Activities:
Payment of Series A perpetual preferred stock dividends
Proceeds from issuance of common stock for public offering, net
Proceeds from issuance of common stock for at-the-market offering, net
Proceeds from issuance of common stock under ESPP
Exercise of warrants for cash
Proceeds from partner companies' ESPP
Partner company's dividends declared and paid
Proceeds from partner companies' sale of stock, net
Partner company's redemption of preferred shares
Proceeds from partner companies' equity offerings and warrant exercises, net
Proceeds from partner companies' at-the-market offering, net
Proceeds from partner company convertible preferred shares, net
Proceeds from partner company's preferred stock offering, net
Payment of costs related to partner company's preferred stock offering
Proceeds from exercise of partner companies' equity grants
Payment of debt issuance costs
Proceeds from exercise of partner companies' options and warrants, net
Partner company's net settlement of shares withheld for taxes
Partner company's cash payout for reverse stock split fractional shares
Payment of partner company's repurchase of stock
Payment of partner company's deferred financing cost
Payment of debt issuance costs associated with Oaktree Note
Proceeds from exercise of partner company's options, net
Repayment of Oaktree Note and debt issuance costs
Repayment of partner company installment payments - licenses
Proceeds from partner company convertible preferred shares
Stock and warrants issued for exchange of partner company preferred shares
Payment of debt issuance costs associated with partner company convertible preferred shares
Proceeds from long-term debt, net
Proceeds from partner company's long-term debt, net
Proceeds from partner company's line of credit
Repayment of partner company's line of credit
Net cash provided by financing activities

Net increase (decrease) in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash at beginning of period
Cash and cash equivalents and restricted cash at end of period
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of non-cash financing and investing activities:
Settlement of restricted stock units into common stock
Unpaid fixed assets
Conversion of partner company convertible preferred shares
Conversion of partner company derivative warrant liabilities
Conversion of partner company annual maintenance fee to a promissory note
Partner company's unpaid intangible assets
Unpaid partner company's debt offering cost
Exchange of partner company convertible preferred shares for common shares
Fair value of assets received by partner company in repurchase transaction
Fair value of supplies received by partner company expensed to research and development
Partner company accounts receivable write-off related to repurchase transaction
Partner company accounts payable write-off related to repurchase transaction
Partner company's deferred purchase consideration
Unpaid partner company's offering cost
Unpaid partner company's repurchase of stock
Partner company's retained earning adjustment
Partner company's reclassification of warrant liability to equity
Partner company derivative warrant liability associated with partner company convertible preferred shares
Partner company's warrants issued in conjunction with debt
Warrants issued in conjunction with debt
Unpaid debt offering cost
Unpaid research and development licenses acquired
Lease Liabilities arising from obtaining right-of-use assets

Comments